Jim Cramer’s bullish on Xilinx and Keysight Technologies, but says Amarin is only for speculation.

Jim Cramer says stocks are only pieces of paper, they shouldn't be worshipped. Investors need to be disciplined, not emotional.

Amarin traded lower after president and CEO John Thero's retirement was viewed as a setback to sign new merger and acquisition deals by a Jefferies analyst.

Jim Cramer says the pandemic will end, but not immediately. He's looking at stocks and sectors poised to move as lockdowns increase.

Amarin's cardiovascular-disease treatment Vascepa met its key endpoint in a late-stage trial in China.

The U.S. Court of Appeals makes its ruling one day after hearing arguments in the case.

Amarin shares are lower after analysts assessed how the judges in the company's patent-case appeal might rule.

Jim Cramer says the stock market may be making new highs, but that doesn't mean we're in a V-shaped economic recovery.

Jim Cramer says that trying to mirror the market can be a bad strategy in times like this.

U.S. retirees may get a big benefit with the next Social Security cost-of-living adjustment for 2023.

Restaurants are moving to adapt to customers with very different wants and desires.

Stanley Druckenmiller, a former colleague of George Soros, bought and sold several stocks in the second quarter.